New treatment option for Implant Stability
Official title Evaluation of Two Mini-implant Diameters in the Infra-zygomatic Crest Region.
ClinicalTrials.gov ID: NCT07337538
What this study is testing
- What it's testing
- The goal of this clinical trials is to compare two diameters, 1.6 and 2 mm, of mini implants both are 12 mm length placed in the infrazygomatic crest region. The main questions it aims to answer are: which diameter is more suitable for IZC region 1.6 or 2mm in terms of primary stability, secondary stability, pain perception and failure rate.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 38. Healthy volunteers may be eligible.
You may be able to join if
- Individuals aged between 15 and 38 years.
- Patients currently undergoing orthodontic treatment with fixed appliances who require mini-implant placement in the upper buccal posterior region...
- Patients willing and able to adhere to the study protocol.
- Recommended for the use of bilateral mini-implants.
You likely can't join if
- Syndromic conditions, facial trauma, or previous bone-related surgery.
The study team makes the final eligibility decision.
Where it's taking place
- Baghdad, Baghdad Governorate, Iraq
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years to 38 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Baghdad, Baghdad Governorate, Iraq. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.